Success Metrics

Active Trials

1(25%)

Phase Distribution

Ph phase_2

50%

Ph phase_3

25%

Ph phase_1

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

1(25.0%)

Phase 2Efficacy & side effects

2(50.0%)

Phase 3Large-scale testing

1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Other(1)

Detailed Status

Not yet recruiting2

unknown1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

N/A

Most Advanced

Phase 3

Trials by Phase

Phase 11 (25.0%)

Phase 22 (50.0%)

Phase 31 (25.0%)

Trials by Status

unknown125%

recruiting125%

not_yet_recruiting250%

Recent Activity

1 active trials

Showing 4 of 4

not_yet_recruitingphase_3

Efficacy and Safety of Utidelone Capsule and Utidelone Injection in Patients With HER-2 Negative Advanced Breast Cancer

NCT07684456

recruitingphase_2

Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma

NCT06841679

not_yet_recruitingphase_2

Utidelone Capsule Monotherapy for Patients with Advanced Solid Tumors

NCT06730581

unknownphase_1

Tolerability of Utidelone Capsule in Patients With Advanced Solid Tumors

NCT05681000

Clinical Trials (4)

Showing 4 of 4 trials

NCT07684456Phase 3

Efficacy and Safety of Utidelone Capsule and Utidelone Injection in Patients With HER-2 Negative Advanced Breast Cancer

Not Yet Recruiting

NCT06841679Phase 2

Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma

Recruiting

NCT06730581Phase 2

Utidelone Capsule Monotherapy for Patients with Advanced Solid Tumors

Not Yet Recruiting

NCT05681000Phase 1

Tolerability of Utidelone Capsule in Patients With Advanced Solid Tumors

Unknown

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4